| Authors: |
Gay F; Division of Hematology, AOU Città della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy. francesca.gay@unito.it., Roeloffzen W; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands., Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.; Department of Medicine, Korea University, Seoul, South Korea., Rosiñol L; Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Clínic de Barcelona, IDIBAPS, and PETHEMA/GEM, Barcelona, Spain., van der Klift M; Department of Internal Medicine, Amphia Hospital, Breda, the Netherlands., Mina R; Division of Hematology, AOU Città della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy., Oriol A; Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona, Spain., Katodritou E; Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece., Wu KL; ZAS Cadix, Antwerp, Belgium., Rodríguez Otero P; Cancer Center Clínica Universidad de Navarra, Pamplona, Spain., Hájek R; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Antonioli E; Hematology Unit, AOU Careggi, Florence, Italy., van Duin M; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., D'Agostino M; Division of Hematology, AOU Città della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy., Martínez-López J; Hematology Department, Hospital Universitario de Octubre, Medicine Department Complutense University, imas12, CNIO, Madrid, Spain., van Leeuwen-Segarceanu EM; Department of Hematology, St. Antonius Hospital, Nieuwegein, the Netherlands., Zamagni E; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.; Department of Medical and Surgical Sciences, Bologna University School of Medicine, Bologna, Italy., van de Donk NWCJ; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, the Netherlands., Weisel KC; Department of Oncology, Hematology and BMT, University Medical Center of Hamburg-Eppendorf, Hamburg, Germany., Pour L; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic., Radocha J; 4th Department of Internal Medicine-Hematology, University Hospital Hradec Kralove, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic., Belotti A; Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy., Schjesvold F; Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Center for B cell malignancies, University of Oslo, Oslo, Norway., Bladé J; Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Clínic de Barcelona, IDIBAPS, and PETHEMA/GEM, Barcelona, Spain., Einsele H; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany., Sonneveld P; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; European Myeloma Network (EMN), Rotterdam, the Netherlands., Boccadoro M; European Myeloma Network (EMN), Turin, Italy., Broijl A; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. |
